Involvement of occupational physicians in the management of MRSA-colonised healthcare workers in Germany – a survey by Madeleine Dulon et al.
Dulon et al. Journal of Occupational Medicine and Toxicology 2013, 8:16
http://www.occup-med.com/content/8/1/16RESEARCH Open AccessInvolvement of occupational physicians in the
management of MRSA-colonised healthcare
workers in Germany – a survey
Madeleine Dulon1*, Frank Haamann1 and Albert Nienhaus1,2Abstract
Background: Colonisation of healthcare workers (HCWs) with methicillin-resistant Staphylococcus aureus strains
(MRSA) is a challenge for any healthcare facility. Persistent carriage of MRSA among HCWs causes special problems,
particularly in occupational-medical care. German occupational physicians responsible for healthcare facilities were
therefore asked about their experience in managing MRSA-colonised HCWs.
Methods: In May 2012, 549 occupational physicians were asked in writing about in-house management of
MRSA-colonised HCWs. The semi-standardised survey form contained questions about collaboration between the
infection control team and the occupational physician, the involvement of the occupational physician in in-house
management of MRSA carriers and the number of persistently colonised HCWs in 2011. The answers were intended
to apply to the largest facility cared for by the occupational physician.
Results: 207 occupational physicians took part in the survey (response rate 38%). In 2011, 73 (35%) occupational
physicians were responsible for the occupational-medical management of an average of four MRSA-colonised
HCWs. Eleven doctors (5.3% of 207) managed a total of 17 persistently colonised HCWs. One of these 17 employees
was dismissed. In the case of MRSA carriage among HCWs, most occupational physicians cooperated with the
infection control team (77%) and 39% of occupational physicians were responsible for the occupational-medical
management of the affected carrier. 65% of facilities had specified policies for the management of MRSA-colonised
HCWs. After the first MRSA-positive screening result, 79% of facilities attempt to decolonise the affected employee.
In 6% of facilities, the colonised HCWs were excluded from work while receiving decolonisation treatment. In 54%
of facilities, infection control policies demand the removal of MRSA carriers from patient care.
Conclusions: Not all facilities have policies for the management of MRSA-colonised HCWs and there are major
differences in occupational consequences for the affected HCWs. In order to protect both the employees and the
patients, standards for the in-house management of MRSA colonisation in HCWs should be developed.
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Occupational diseaseBackground
In recent reviews, the prevalence of methicillin-resistant
Staphylococcus aureus (MRSA) in healthcare workers
(HCWs) was estimated to be about 5% [1,2]. MRSA car-
riage of HCWs was higher in the endemic setting (8.1%)
than during outbreaks (3.9%) [1]. The main reservoir of* Correspondence: madeleine.dulon@bgw-online.de
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developing invasive infections [7].
The main route of transmission of MRSA is considered
to be from patient to patient via the contaminated hands of
HCWs [1,2]. Staphylococcal hand carriage in HCWs is
usually transient – detectable after a shift and gone before
the next shift [1]. Still, HCWs have been implicated as the
source in a number of published outbreak reports [1,8].
Particularly HCWs with skin lesions or upper respiratory
tract infections – associated with higher rates of persistent
colonisation – are considered to be at risk of transmitting
MRSA to patients [1]. Such events are rare [9] and the
relative importance of the colonised staff in the transmis-
sion of MRSA in the endemic setting is unclear [1,2]. This
might explain why the recommended infection control
measures in national guidelines are controversial [1,7].
German guidelines recommend the decolonisation of a
colonised healthcare worker and removal of the affected
employee from patient care until proven eradication
[10-12]. There is general uncertainty about the optimal
policy [13] and practical issues, such as management of
persistently colonised HCWs, are unresolved questions
[1,7]. There is also the fact that compensation for prevent-
ive decolonisation measures in HCWs is neither provided
by statutory health insurance nor by statutory accident
insurance. Therefore, with respect to stigmatisation and oc-
cupational consequences for persistently colonised HCWs,
a solution in insurance law has been demanded [13,14].
When caring for MRSA-colonised HCWs, occupational
medicine and infection control are subject to two different
and potentially contradictory legal regulations in Germany.
In order to protect employees working with biological
substances, the German Ordinance on Biological Agents
(BioStoffV) regulates occupational healthcare which must be
provided by the occupational physician who is responsible
for the affected facility [15]. In order to protect patients from
nosocomial infections, the German Infection Protection Act
(IfSG) regulates the prophylactic measures of the spread of
resistant pathogens within the medical facility [16]. Infection
control practitioners are responsible for implementing this
law. Nowhere is it explicitly specified that these two
professional groups should work together in the practical
management of colonised HCWs in the health service.
The purpose of this paper is to provide information on
the kind of policies that exist for the management of
MRSA-colonised HCWs and to investigate the extent
to which occupational physicians are involved in the
occupational-medical care of MRSA carriers in general and
in particular of persistently colonised HCWs.
Methods
In May 2012, 549 occupational physicians were asked in
writing about in-house management of MRSA-colonised
HCWs. The occupational physicians were identified from adata base relating to addresses of participants invited to
training courses, organised from the German Social
Accident Insurance Institution for the Health and Welfare
Services (BGW), which is the workers’ compensation board
for all non-public healthcare and welfare providers. Only
those physicians responsible for occupational-medical care
in healthcare facilities were chosen. The standardised ques-
tionnaire was administered to solicit information about the
involvement of occupational physicians in in-house man-
agement of MRSA carriers, occupational-medical care of
MRSA carriers and the numbers of persistent carriers
which were cared for by the occupational physician. The
answers were intended to apply to the year 2011 and the
largest facility cared for by the occupational physician. The
survey was carried out anonymously and study participation
was voluntarily. Data processing was in accordance with the
German Data Protection Act. To increase the response rate,
three skin care cases (“Hautschutzkoffer”) were raffled for
use in the occupational health practice. The analysis was
descriptive. Data are presented as count (percentages).Results
Of the eligible participants, 207 (38%) of 549 occupational
physicians chose to enrol in the survey. The physicians
were responsible for various areas in the health service,
including facilities for clinical and nursing care, homes for
the handicapped and physiotherapy clinics. Regulations for
the management of MRSA-colonised HCWs existed in
65% of the facilities, specified as a component of an
infection control protocol or as part of the employment
agreement (Table 1).
After a positive MRSA finding in a healthcare worker,
there was collaboration between the occupational physician
and the responsible infection control practitioners in 77% of
the facilities. 62% of the occupational physicians declared
that the responsibility for coordinating eradication therapy
had been clarified in the facility they were responsible for. In
36% of cases, the occupational physician was responsible for
coordination of the measures of the eradication therapy,
either alone or in collaboration with the infection control
professional, the attending physician or the nursing service
(no table). 42% of the occupational physicians considered
that they were always informed of positive MRSA findings
in HCWs. 39% of the occupational physicians were respon-
sible for occupational-medical care of MRSA carriers,
including notification and counselling. 15% of the occupa-
tional physicians were responsible for screening procedures.
In 2011, 73 occupational physicians (35%) managed a
mean of four employees colonised with MRSA. The
affected employees predominantly worked in hospitals
and nursing homes and more rarely in homes for the
handicapped or in an outpatient service (Table 2). A few
were working in physiotherapy or veterinary clinics.
Table 1 Involvement of occupational physicians in the in-house management of MRSA-colonised healthcare workers
(n=207)
Statement Responses N %
Regulations for the management of
MRSA-colonised employees exist
As a component of an infection control protocol 123 59
As part of an employment agreement 12 6
Not established 72 35
Collaboration takes place between occupational physician
and infection control staff with respect to MRSA-colonised employees
Yes 155 77
No 52 23
Responsibility for the coordination of the
eradication therapy is regulated
Yes 128 62
No 79 38





The occupational physician is responsible for
dealing with MRSA-colonised employees
Yes 88 39
No 119 61
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HCWs were forced to undergo decolonisation therapy in
79% of the facilities after the first positive screening re-
sult (Table 3). In 7% of the facilities, decolonisation was
only recommended when the HCWs exhibited risk fac-
tors, such as a weakened immune system, a wish for
children, symptoms of discomfort or if they worked with
patients at risk.
Forty-four occupational physicians (21%) had to evalu-
ate the success of decolonisation treatment by follow-up
cultures in the year 2011 (no table). Follow-up cultures
were taken by 66% (29/44) on three consecutive days,
starting three days after completion of treatment mea-
sures. Additional follow-up cultures after one and three
months were taken by eleven physicians.
In 70% of the facilities, the MRSA-colonised HCWs
were subject to work restrictions, although there were
differences in the extent of the restrictions (Table 4). In
6% of the facilities, colonised HCWs were forced to take
leave of absence until documentation of negative follow-Table 2 Areas of work in which MRSA-colonised
healthcare workers were managed by occupational
physicians in 2011 (n=73)
Area of work N1
Hospital, clinic, convalescence clinic 54
Nursing home 26
Home for the handicapped 10
Outpatient service 8
Other (physiotherapy, veterinary clinic, ambulance service) 4
1 Multiple answers possible.up cultures was obtained. In almost half the facilities
(54%), colonised HCWs were able to continue work, but
not with patient contact or in high-risk units, nor if they
suffered from a chronic skin disease. In 10% of the facil-
ities, colonised HCWs were allowed to continue work
without restrictions other than compliance with hand
hygiene measures and use of protective equipment dur-
ing high-risk activities.
In 2011, eleven occupational physicians managed a total
of 17 HCWs who were persistently colonised with MRSA.
In one case, the employee was dismissed as a consequence
of the persistent colonisation, presumably for health
reasons.Discussion
Colonised HCWs are generally asymptomatic, but they are
likely to be important in the transmission of MRSA, most
frequently acting as vectors [1]. If HCWs are still colonised
with MRSA after several attempts at decolonisation, it mayTable 3 Regulations on the decolonisation of healthcare
workers after MRSA- positive screening results; answers
given by occupational physicians (n=207)
Regulations on decolonisation N %
After first positive finding 163 79
If the healthcare worker displays risk factors1 14 7
Unknown 30 14
1 Immune deficiency, a wish for children, symptoms of discomfort, contact
with patients at risk.
Table 4 Work restrictions for MRSA-colonised healthcare
workers to continue their work; answers given by
occupational physicians (n=205)
Work restrictions N %
1 (= compliance with hand hygiene
and use of protective equipment1)
20 10
1 + No patient contact 28 14
1 + No work in high-risk units2 31 15
1 + No patient contact, no work in high-risk units2 32 15
1 + No chronic skin diseases, no
patient contact, no work in high-risk units2
21 10
Forced leave of absence as long as
screening results are positive
12 6
Unknown/not fixed 61 30
1 Gloves, protective clothing, disposable aprons and a face mask for
high-risk activities.
2 Units containing vulnerable patients at high risk of developing
invasive infection.
Dulon et al. Journal of Occupational Medicine and Toxicology 2013, 8:16 Page 4 of 6
http://www.occup-med.com/content/8/1/16not be possible for them to continue their professional
work. HCWs have good reason to be worried about the po-
tential occupational consequences of an MRSA colonisa-
tion, as has been reported by several authors [8,13,14,17]
and is evident from the employee who was dismissed. Our
survey showed that there are major differences between
healthcare facilities with respect to management of MRSA-
colonised HCWs. The policies range from unrestricted con-
tinued work with adherence to basic infection control
guidelines, to continued work with major or minor restric-
tions in the activities or area of work, to forced leave of
absence.
The question of whether and for how long colonised
HCWs should be excluded from work is unresolved
[1,2,7]. Official German recommendations lay down that
MRSA carriers can resume patient contact once they
have had MRSA-negative swabs on three consecutive
days, starting three days after completion of the eradica-
tion treatment [10]. However, this specific topic is given
a low level of evidence [10], as the effectiveness of differ-
ent screening strategies for considering staff (or patients)
free from MRSA carriage remains controversial [1,2,7].
In a few German studies, clinical infection control
professionals have reported that they do not require
MRSA-colonised HCWs to be removed from patient
care, provided that the affected HCWs comply with
basic infection control measures [18,19]. However, these
in-house regulations did not apply during outbreaks or
when colonised HCWs were suffering from chronic skin
diseases [18] or were working in high-risk units [19].
German recommendations for facilities outside the clin-
ical setting, for nursing homes or domestic care, con-
sider that adherence to the basic principles of hand
hygiene is the most important measure and allow
colonised HCWs to continue to work [20]. Thisrecommendation is restricted to non-outbreak situations
and is being justified with the reduced risk of transmit-
ting resistant strains in long-term care facilities [21].
About 80% of the occupational physicians cooperated
with infection control practitioners with respect to the
management of MRSA-colonised HCWs. As a limitation
of our study, the quality and extent of this collaboration
and the point of view of the infection control practitioners
were not assessed. However, only 42% of occupational
physicians stated that they always felt adequately informed
about MRSA findings in employees. In general, it was
striking that 30% of occupational physicians failed to pro-
vide information about work restrictions and 14% did not
know the regulation scheme for the decolonisation in the
facility they were responsible for. This lack of information
may either be due to the lack of binding regulations within
the facility, or may be taken as a sign that the occupational
physician is not adequately involved in the in-house man-
agement of MRSA carriers. The reason that occupational
physicians are not involved in staff screening, is probably
that staff screening in Germany is only advocated in out-
breaks [10] and the control measures during outbreaks are
the responsibility of the infection control experts [16].
Nevertheless, close collaboration between the occupa-
tional physician and infection control practitioners is es-
sential in managing an MRSA-colonised employee, as both
the employee and the patients must be protected [12].
Guidelines for this collaboration are given by the “consen-
sus recommendation Baden-Wuerttemberg”, which was
developed by infection control professionals, public health
experts and occupational physicians [22]. The occupational
physician can serve as a case manager for the MRSA-
colonised HCW. However, in order to be able to create
a confidential relationship with the healthcare worker
afflicted, anonymity of this employee should be ensured
and an agreement between management and representa-
tives of the workers concerning social safety of the em-
ployee afflicted is needed.
In the present study, a total of 17 persistently colonised
HCWs were treated by occupational physicians in the
course of 2011. However, this number cannot be used for
an estimation of the prevalence of persistently colonised
MRSA carriers among German HCWs because of missing
denominator data and the method of recording used in our
study. In all but one of these 17 cases, persistent carriage
was established on the basis of two or more unsuccessful
eradications. Although there is no general consensus on
how to define persistent carriage of MRSA, repeated unsuc-
cessful eradication seems to be the current standard in clin-
ical practice [22].
The diversity and uncertainty regarding the occupational-
medical care of persistent MRSA colonisation is partly
caused by missing regulations regarding the coverage of the
cost involved. In Germany, infections associated with
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medical as well as the occupational and social rehabilitation
cost can be covered by the workers’ compensation board
[23,24]. So far, MRSA colonisation is not considered an oc-
cupational disease and the compensation board is therefore
not able to cover the cost for testing and treating afflicted
HCWs. However, persistent colonisation with MRSA is as-
sociated with an increase in the risk of infection [25,26].
Therefore decolonisation of HCWs with persistent colon-
isation not only reduces nosocomial transmission, but will
reduce infection risk for the HCW and therefore avoids the
development of an occupational disease as well. As it is the
task of the compensation board to avoid the development
of a looming occupational disease, the cost of decolonisa-
tion can be covered by the compensation board [27].
In 2011, 73 occupational physicians (35% of all re-
sponders) were responsible for an average of four HCWs
colonised with MRSA. However, these numbers do not
allow for the estimation of the prevalence of MRSA col-
onisation of HCWs in Germany. First of all, the response
rate of our survey was low (38%), which hampers the
transferability of our study results. As occupational phy-
sicians who had experience with MRSA might have been
more likely to participate in the survey, the number of
colonised HCWs might be overestimated. Secondly, the
involvement of occupational physicians in the manage-
ment of MRSA was quite diverse and often non-existent.
As our only source of information was the occupational
physicians, this might have introduced an underestima-
tion of the number of HCWs colonised.
Conclusion
Even though some recommendations exist, the manage-
ment of HCWs with MRSA colonisation is not stan-
dardised in Germany. Important questions in this realm
remain unsolved, e.g. which tasks can be performed by
colonised HCWs, when should preventive decolonisation
treatment be performed, who should be responsible for the
management of MRSA-colonised HCWs, and who covers
the cost involved? Answering these questions is key to the
development and implementation of standards for the
management of MRSA-colonised HCWs.
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